Janice MacKinnon – Saskatchewan Model Shows How Private Clinics Can Play in a Public System
To: Canadians concerned about healthcare From: Janice MacKinnon Date: October 6, 2021 Re: Saskatchewan Model Shows How Private Clinics Can Play in a Public System The federal election featured a renewed debate about private healthcare in Canada. Yet only in Canada would the topic of private healthcare spark any debate. Many OECD nations that have systems that are less […] Parisa Mahboubi – COVID Benefits are Ending. Will Workers Return?
From: Parisa Mahboubi To: Canadian labour force observers Date: October 4, 2021 Re: COVID Benefits are Ending. Will Workers Return? Canada’s COVID-related economic recovery measures are set to end soon. What are the likely outcomes and what are the potential steps the federal government can take to soften the blow? In the early days of the pandemic, the […] Canada Should Negotiate A Fairer Share Of Drug R&d Costs – Financial Post Op-ed
Big changes are afoot in the way patent drugs are priced in Canada. At present, Canada’s Patented Medicine Prices Review Board (PMPRB), a federal agency, is responsible for setting maximum prices for patented drugs (i.e., pharmaceuticals, biologics and vaccines). The agency has been criticized for failing to rein in prices, which are higher than in some peer countries. This criticism is unfair: the tools the PMPRB was given to regulate drug prices when it was established in 1987 have become less effective over time.
To address this problem, the federal government has authorized the PMPRB to introduce new pricing regulations, now scheduled to come into force in January. We think this is the wrong strategy. Instead of relying on…
Trebilcock, Poliwoda – The Trips Vaccine Waiver Controversy
From: Michael J. Trebilcock and Dan Poliwoda To: Canadians concerned about vaccine equity Date: September 23, 2021 Subject: The TRIPS Vaccine Waiver Controversy The vastly differing rate at which developed and developing countries have been able to procure COVID-19 vaccines has exposed major inequities in global vaccine access. In an effort to boost developing countries access to COVID-19 vaccines, […] Widespread Devastation For Seniors
The impact of COVID-19 on Canadian seniors has been devastating. Unfortunately, new research suggests that official counts likely underestimate COVID-19 deaths among the senior population at large. It is well known that the pandemic took a heavy toll on seniors living in long-term care and retirement homes, however, recalibrated estimates suggest that 62 percent of […] Rosalie Wyonch – Learning From Deadly Lessons: Seniors’ Care And Covid-19
From: Rosalie Wyonch To: Canadians concerned about long-term care Date: August 30, 2021 Subject: Learning from Deadly Lessons: Seniors’ Care and COVID-19 The impact of COVID-19 on Canadian seniors, in particular for residents of long-term care and retirement homes, has been devastating. With more than 15,000 resident and 30 staff deaths, Canadians are expecting governments to improve residential […] Cutting Square Deals: Drug Prices, Regulation, and Patent Protection
The Study In Brief Over the past several years, the federal government has consulted widely in formulating new rules for the regulation of brand-name drug prices through the Patented Medicine Prices Review Board (PMPRB) and a long-delayed set of rules that are expected to result in large price reductions, now slated to come into force […] Drummond, Sinclair, Gladkov – Reach For The Healthcare Podium
From: Don Drummond, Duncan Sinclair and Philipp Gladkov To: Canadians concerned about healthcare Date: August 13, 2021 Re: Reach for the Healthcare Podium Healthcare’s goals are two-fold. Treating people to help them recover from ill-health, injury, and disability has been the predominant focus since the establishment of medicare as a key component of Canada’s social safety net. Meanwhile, optimizing […] Best in Health: Creating a Comprehensive Health Information Ecosystem
By Don Drummond, Duncan Sinclair and Philipp Gladkov Executive Summary Like others, Canada’s healthcare ‘system’ is reactive. It is focused on restoring to good health people who become ill or injured. It does relatively little to keep people healthy – to promote good health. Correcting this imbalance is the primary focus of this report. To […] S3 E15: The Charter and Vaccine Passports
As the debate over vaccine passports continues, time is slipping away. In the report “Vaccine Ins and Outs: An Exploration of the Legal Issues Raised by Vaccine Passports,” two of its authors joined the C.D. Howe Institute Podcast to explain why a well designed passport will work – and is critical to putting COVID-19 behind us. Thomas, Flood, Krishnamurthy, Tanner, Wilson – Are Vaccine Passports Discriminatory?
From: Bryan Thomas, Colleen M. Flood, Vivek Krishnamurthy, Ryan Tanner and Kumanan Wilson To: Canadians Concerned about Vaccine Passports Date: July 29, 2021 Re: Are Vaccine Passports Discriminatory? Our new C.D. Howe Institute Working Paper explores the legal dimensions of vaccine passports under the Charter of Rights and Freedoms, the privacy implications of such a system and other facets. […] Blomqvist, Grootendorst – Selling Drugs To The Us
From: Åke Blomqvist and Paul Grootendorst To: The Honourable Patty Hajdu, Minister of Health Date: July 22, 2021 Re: Selling Drugs to the US President Joe Biden recently announced his intention to work with state governments to encourage American buyers to import pharmaceuticals from Canada, where drug prices are lower. The government of Canada should […]